Life Sciences

This issue of Vital Signs, released on March 28, 2013, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences and Advanced Medical Technology.

The aim of this research service was to provide insight into the market for revitalization and construction of new hospitals in the country and in addition quantify this market. This research service provides a detailed overview of the structure of the public and private hospital sector in Kenya. An overview of the healthcare structure as well as h...

This research service focuses on antiviral/antiretroviral therapeutics for the treatment of infection with blood-borne pathogens of current global interest, specifically viral hepatitis and HIV/AIDS. A product and pipeline assessment is provided for marketed and investigational products and combination regimens for the treatment of HBV, HCV, and H...

This research service focuses on prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided, along with additional supporting information, such as clinical trial timelines and results, historical and projected launch timeline...

This market insight provides the list of key marketed products as well key compounds in phase 2 and 3 clinical trials in the global nonmalignant blood disorders market, classified into eight major segments including antianaemics, anticoagulants, antifibrinolytics, fibrinolytics, blood substitutes, plasma expanders, platelet aggregation inhibitors, ...

This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...

This article explains in detail the various challenges that confront the generic drug manufacturers in the global generic pharmaceuticals market. The defense strategies adopted by branded pharmaceutical companies to delay generic versions of their products have also been discussed. Strategic recommendations for the success of global generic compani...

This research service presents a study of the interventional radiology and cardiology equipment market in the Asia-Pacific region. It provides an in-depth analysis of the current trends, market size, revenue forecast, unit shipment forecast, technology trends, drivers and restraints, and penetration analysis of the interventional radiology and car...

This issue of Vital Signs, released on March 7, 2013, provides an insight in to battle between FDA and branded and generic pharmaceutical companies. Additionally, a company spotlight is provided for PLC Diagnostics. PLC Diagnostics is an early stage startup, developing the next generation of handheld point-of-care testing devices.